Salveen Richter
Stock Analyst at Goldman Sachs
(3.36)
# 1,046
Out of 5,105 analysts
204
Total ratings
41.23%
Success rate
5.79%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGIO Agios Pharmaceuticals | Maintains: Neutral | $40 → $25 | $27.27 | -8.32% | 10 | Nov 20, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Neutral | $9 → $11 | $10.55 | +4.27% | 3 | Nov 5, 2025 | |
| QURE uniQure | Maintains: Neutral | $56 → $38 | $19.51 | +94.77% | 9 | Nov 4, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $14 → $16 | $21.53 | -25.69% | 4 | Oct 30, 2025 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | $45 → $65 | $80.82 | -19.57% | 5 | Sep 26, 2025 | |
| APLS Apellis Pharmaceuticals | Downgrades: Sell | $26 → $18 | $25.23 | -28.66% | 9 | Sep 26, 2025 | |
| IMNM Immunome | Initiates: Buy | $26 | $19.57 | +32.86% | 1 | Sep 22, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $504 → $566 | $397.55 | +42.37% | 6 | Sep 16, 2025 | |
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $44 → $38 | $10.84 | +250.55% | 5 | Aug 12, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Neutral | $10 → $19 | $21.53 | -11.75% | 6 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $15 → $17 | $27.15 | -37.38% | 9 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $16.86 | +119.45% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $53 → $47 | $56.68 | -17.08% | 4 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $124 → $104 | $53.31 | +95.09% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $41 | $17.57 | +133.35% | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $15.44 | -35.23% | 11 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $917 → $804 | $741.29 | +8.46% | 11 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 → $197 | $174.10 | +13.15% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $8.03 | +124.16% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $120.40 | -20.27% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $99 → $51 | $29.46 | +73.12% | 10 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $17.98 | +122.47% | 5 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $12 | $9.02 | +33.04% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $95.41 | -26.63% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $67 → $76 | $36.23 | +109.77% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $317.74 | +10.15% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $452.04 | +23.66% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $26.51 | -81.14% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $1.51 | +1,952.98% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $297.64 | -24.41% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $4.10 | +436.59% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $34.46 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $4.99 | +501.20% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $4.33 | +107.85% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $5.79 | -48.19% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $5.14 | +16.73% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $74.59 | -42.35% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $4.68 | -57.26% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $18.00 | +455.71% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $560 → $600 | $9.80 | +6,025.57% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $111.56 | -55.18% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $70.09 | -35.80% | 1 | Mar 17, 2020 |
Agios Pharmaceuticals
Nov 20, 2025
Maintains: Neutral
Price Target: $40 → $25
Current: $27.27
Upside: -8.32%
Amicus Therapeutics
Nov 5, 2025
Maintains: Neutral
Price Target: $9 → $11
Current: $10.55
Upside: +4.27%
uniQure
Nov 4, 2025
Maintains: Neutral
Price Target: $56 → $38
Current: $19.51
Upside: +94.77%
Arcus Biosciences
Oct 30, 2025
Maintains: Neutral
Price Target: $14 → $16
Current: $21.53
Upside: -25.69%
Ionis Pharmaceuticals
Sep 26, 2025
Upgrades: Neutral
Price Target: $45 → $65
Current: $80.82
Upside: -19.57%
Apellis Pharmaceuticals
Sep 26, 2025
Downgrades: Sell
Price Target: $26 → $18
Current: $25.23
Upside: -28.66%
Immunome
Sep 22, 2025
Initiates: Buy
Price Target: $26
Current: $19.57
Upside: +32.86%
Alnylam Pharmaceuticals
Sep 16, 2025
Maintains: Buy
Price Target: $504 → $566
Current: $397.55
Upside: +42.37%
4D Molecular Therapeutics
Aug 12, 2025
Maintains: Buy
Price Target: $44 → $38
Current: $10.84
Upside: +250.55%
Sarepta Therapeutics
Aug 7, 2025
Maintains: Neutral
Price Target: $10 → $19
Current: $21.53
Upside: -11.75%
Aug 7, 2025
Maintains: Sell
Price Target: $15 → $17
Current: $27.15
Upside: -37.38%
Jun 16, 2025
Initiates: Buy
Price Target: $37
Current: $16.86
Upside: +119.45%
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $56.68
Upside: -17.08%
May 5, 2025
Maintains: Buy
Price Target: $124 → $104
Current: $53.31
Upside: +95.09%
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $17.57
Upside: +133.35%
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $15.44
Upside: -35.23%
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $741.29
Upside: +8.46%
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $174.10
Upside: +13.15%
Feb 27, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $8.03
Upside: +124.16%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $120.40
Upside: -20.27%
Jan 29, 2025
Downgrades: Neutral
Price Target: $99 → $51
Current: $29.46
Upside: +73.12%
Jan 28, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $17.98
Upside: +122.47%
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $9.02
Upside: +33.04%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $95.41
Upside: -26.63%
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $36.23
Upside: +109.77%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $317.74
Upside: +10.15%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $452.04
Upside: +23.66%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $26.51
Upside: -81.14%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $1.51
Upside: +1,952.98%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $297.64
Upside: -24.41%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $4.10
Upside: +436.59%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $34.46
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $4.99
Upside: +501.20%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $4.33
Upside: +107.85%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $5.79
Upside: -48.19%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $5.14
Upside: +16.73%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $74.59
Upside: -42.35%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $4.68
Upside: -57.26%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $18.00
Upside: +455.71%
Mar 4, 2021
Upgrades: Buy
Price Target: $560 → $600
Current: $9.80
Upside: +6,025.57%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $111.56
Upside: -55.18%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $70.09
Upside: -35.80%